These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2150352)

  • 21. Heterogeneity of growth hormone (GH) release by individual pituitary adenoma cells from acromegalic patients, as determined by the reverse hemolytic plaque assay: effects of SMS 201-995, GH-releasing hormone and thyrotropin-releasing hormone.
    Hofland LJ; van Koetsveld PM; van Vroonhoven CC; Stefanko SZ; Lamberts SW
    J Clin Endocrinol Metab; 1989 Mar; 68(3):613-20. PubMed ID: 2493040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth hormone secretion in recently operated acromegalic patients.
    van den Berg G; Frölich M; Veldhuis JD; Roelfsema F
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1706-15. PubMed ID: 7989479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The correlationship between basal prolactin levels and the suppressive effect of CB-154 or L-DOPA on GH release in acromegalic patients (author's transl)].
    Hara I; Kataoka K; Tomita A; Takanohashi M; Nakane T; Kuwayama A; Kageyama N
    Nihon Naibunpi Gakkai Zasshi; 1979 Jan; 55(1):16-24. PubMed ID: 581754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cabergoline in the treatment of acromegaly: a study in 64 patients.
    Abs R; Verhelst J; Maiter D; Van Acker K; Nobels F; Coolens JL; Mahler C; Beckers A
    J Clin Endocrinol Metab; 1998 Feb; 83(2):374-8. PubMed ID: 9467544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nitric oxide modulates in vivo and in vitro growth hormone release in acromegaly.
    Cuttica CM; Giusti M; Bocca L; Sessarego P; De Martini D; Valenti S; Spaziante R; Giordano G
    Neuroendocrinology; 1997 Dec; 66(6):426-31. PubMed ID: 9430448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
    Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N
    J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of growth hormone-releasing factor (GRF) and dopamine on growth hormone (GH) secretion in acromegaly.
    Giusti M; Lomeo A; Mazzocchi G; Mignone D; Sessarego P; Monachesi M; Giordano G
    J Endocrinol Invest; 1985 Jun; 8(3):203-6. PubMed ID: 3928732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of desensitization of adenomatous somatotrophs to growth-hormone releasing hormone in acromegaly.
    Spada A; Elahi FR; Arosio M; Sartorio A; Guglielmino L; Vallar L; Faglia G
    J Clin Endocrinol Metab; 1987 Mar; 64(3):585-91. PubMed ID: 3102543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the effect of levodopa and somatostatin on the plasma levels of growth hormone, insulin, glucagon and prolactin in acromegaly.
    Dunn PJ; Donald RA; Espiner EA
    Clin Endocrinol (Oxf); 1976 Mar; 5(2):167-74. PubMed ID: 1269163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The growth hormone responses to L-dopa and TRH in acromegaly.
    Jialal I; Naidoo C; Nathoo BC; Rajput MC; Joubert SM
    J Endocrinol Invest; 1984 Jun; 7(3):235-7. PubMed ID: 6432894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recovery from paradoxical growth hormone responses in acromegaly after transphenoidal selective adenomectomy.
    Hoyte KM; Martin JB
    J Clin Endocrinol Metab; 1975 Oct; 41(4):656-9. PubMed ID: 809457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulation of growth hormone release by vasoactive intestinal polypeptide from human pituitary adenomas in vitro.
    Matsushita N; Kato Y; Katakami H; Shimatsu A; Yanaihara N; Imura H
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1297-300. PubMed ID: 6795228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyproheptadine-mediated inhibition of growth hormone and prolactin release from pituitary adenoma cells of acromegaly and gigantism in culture.
    Ishibashi M; Fukushima T; Yamaji T
    Acta Endocrinol (Copenh); 1985 Aug; 109(4):474-80. PubMed ID: 2994332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of dopamine on plasma growth hormone and prolactin levels in normal and acromegalic subjects.
    Camanni F; Massara F; Belforte L; Rosatello A; Molinatti GM
    J Clin Endocrinol Metab; 1977 Mar; 44(3):465-73. PubMed ID: 838847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of tamoxifen on GH and PRL secretion by human pituitary tumors.
    Lamberts SW; de Quijada M; Klijn JG
    J Endocrinol Invest; 1980; 3(4):343-7. PubMed ID: 7204884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of dopamine and bromocriptine on secretion of growth hormone by pituitary growth hormone secreting tumor in cell culture].
    Deng J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Oct; 12(5):330-4. PubMed ID: 1966332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopaminergic binding sites in human pituitary adenomas other than prolactinomas.
    Serri O; Marchisio AM; Collu R; Hardy J; Somma M
    Horm Res; 1984; 19(2):97-102. PubMed ID: 6706294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatostatin receptors in human growth hormone and prolactin-secreting pituitary adenomas.
    Moyse E; Le Dafniet M; Epelbaum J; Pagesy P; Peillon F; Kordon C; Enjalbert A
    J Clin Endocrinol Metab; 1985 Jul; 61(1):98-103. PubMed ID: 2860120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocrine, biochemical, and morphological studies of a pituitary adenoma secreting growth hormone, thyrotropin (TSH), and alpha-subunit: evidence for secretion of TSH with increased bioactivity.
    Beck-Peccoz P; Piscitelli G; Amr S; Ballabio M; Bassetti M; Giannattasio G; Spada A; Nissim M; Weintraub BD; Faglia G
    J Clin Endocrinol Metab; 1986 Apr; 62(4):704-11. PubMed ID: 2419356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years.
    Abbassioun K; Amirjamshidi M; Mehrazin A; Khalatbary I; Keynama M; Bokai H; Abdollahi M
    Surg Neurol; 2006 Jul; 66(1):26-31; discussion 31. PubMed ID: 16793431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.